Marcos Malumbres
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study.
Journal: Breast cancer research and treatment
Published: November 04, 2025
Combination of Lurbinectedin Plus Irinotecan: Preclinical and Early Clinical Results in Patients With Relapsed SCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 25, 2025
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 27, 2024
Harnessing Senolytics and PARP Inhibition to Expand the Antitumor Activity of CDK4/6 Inhibitors in Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: October 13, 2024
Mosaic variegated aneuploidy in development, ageing and cancer.
Journal: Nature reviews. Genetics
Published: June 27, 2024
Cross Talk Between Metabolism and the Cell Division Cycle.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 23, 2024
Rapid mechanical phenotyping of breast cancer cells based on stochastic intracellular fluctuations.
Journal: iScience
Published: February 17, 2024
PP2A-B55 phosphatase counteracts Ki-67-dependent chromosome individualization during mitosis.
Journal: Cell reports
Published: November 02, 2023
Correction to: CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 02, 2023
Last Updated: 09/26/2026